Tag: study

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

Global Jewelry Market Size to Reach USD 659 Billion by 2035, Growing at 5.6% CAGR | Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Jewelry Market size & share revenue was valued at approximately USD 382 Billion in 2025 and is expected to reach USD 403 Billion in 2026 and is expected to reach around USD 659 Billion by 2035, at a CAGR of 5.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Harry Winston, Dora International, Malabar Gold & Diamonds, Pandora, Louis Vuitton SE, Chow Tai Fook, GRAFF, Richemont, Signet Jewelers Ltd., H. Stern, Swarovski AG, Damiani, Blue Nile, Buccellati, De Beers, Jacob & Co., Tiffany & Co., Fame Diamonds, Gemco Designs, Mauboussin and others.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Jewelry Market size & share revenue was valued at approximately USD 382 Billion in 2025 and is expected to reach USD 403 Billion in 2026 and is expected to reach around USD 659 Billion by 2035, at a CAGR of 5.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Harry Winston, Dora International, Malabar Gold & Diamonds, Pandora, Louis Vuitton SE, Chow Tai Fook, GRAFF, Richemont, Signet Jewelers Ltd., H. Stern, Swarovski AG, Damiani, Blue Nile, Buccellati, De Beers, Jacob & Co., Tiffany & Co., Fame Diamonds, Gemco Designs, Mauboussin and others.

Automated People Mover Market to Reach USD 4.86 Billion by 2032 – Credence Research

LONDON, June 9, 2026 /PRNewswire/ -- The "Automated People Mover Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added...

Vigloo Unlocks High-Cost Racing Drama as Short-Form in Just Six Weeks With AI

Vigloo’s new AI-produced microdrama, "Final Lap: Love & Betrayal," premieres June 9, leveraging AI to make high-cost racing content viable for mobile.

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

PRESS RELEASE

Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

New Program Connects Biotech and Pharmaceutical Partners with Einstein's Aging Research Expertise and Scientific Infrastructure BRONX, N.Y., June 9, 2026 /PRNewswire/ -- Albert Einstein...

ANTIKYTHERA: HUBLOT FUSES ANCIENT HISTORY, WATCHMAKING INNOVATION AND PIONEERING EXPLORATION

NYON, Switzerland, June 9, 2026 /CNW/ -- As part of its commitment to scientific research, innovation and heritage preservation, Hublot has partnered with Swiss...

CheckProof Releases Industry Report on Maintenance and Safety in Construction Materials Operations

STOCKHOLM, June 9, 2026 /PRNewswire/ -- CheckProof, the operations management platform built for construction materials and heavy industry, today published 'Mind the Gap: A Construction...

Eagle Scout Pathway Produces Young Adults with Measurably Higher Well-Being, Purpose, Leadership and Civic Engagement — Exactly What Families Need Today

New Harris Poll research of more than 3,000 U.S. adults finds Eagle Scouts report 2x lower loneliness, significantly higher purpose and leadership and stronger...

DNV Validates Fluence 99% Fleet Performance Availability for Large Energy Storage Projects

Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support

Comprehensive DNV analysis confirms strong operational performance, providing a verified benchmark for consistent uptime and revenue support

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination

Four Michigan students advance to national finals of the Mott Million Dollar Challenge in Flint

Long Beach Community Care Campus Expansion Advances with $10 Million Investment from Centene Foundation and Health Net

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

Global Jewelry Market Size to Reach USD 659 Billion by 2035, Growing at 5.6% CAGR | Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

Automated People Mover Market to Reach USD 4.86 Billion by 2032 – Credence Research

Vigloo Unlocks High-Cost Racing Drama as Short-Form in Just Six Weeks With AI

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

ANTIKYTHERA: HUBLOT FUSES ANCIENT HISTORY, WATCHMAKING INNOVATION AND PIONEERING EXPLORATION

CheckProof Releases Industry Report on Maintenance and Safety in Construction Materials Operations

Eagle Scout Pathway Produces Young Adults with Measurably Higher Well-Being, Purpose, Leadership and Civic Engagement — Exactly What Families Need Today

DNV Validates Fluence 99% Fleet Performance Availability for Large Energy Storage Projects

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in Alaska

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in Alaska

BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback

Explore

Press Releases

News & Opinion

Living

Others

Follow us